(Q33490023)

English

Phase I clinical trial of a 3-day divided dose schedule of ifosfamide (NSC 109724).

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Phase I clinical trial of a 3-day divided dose schedule of ifosfamide (NSC 109724). (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit